title: Lamivudine: a new strategy to suppress HBV replication in the pretransplant setting.
authors.affiliation: Gastroenterology and Liver Transplant Units, H.S. João, Porto, Portugal.
authors.forename: G
authors.initials: G
authors.lastname: Macedo
authors.forename: J C
authors.initials: JC
authors.lastname: Maia
authors.forename: A
authors.initials: A
authors.lastname: Gomes
authors.forename: M
authors.initials: M
authors.lastname: Beleza
authors.forename: A
authors.initials: A
authors.lastname: Teixeira
authors.forename: A
authors.initials: A
authors.lastname: Ribeiro
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D006509:Hepatitis B / Q000175:diagnosis / Q000517:prevention & control*; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation; D008875:Middle Aged; D011292:Premedication; D012008:Recurrence; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D019259:Lamivudine